Showing:
◈ Informa Pharma Intelligence×
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.
Northern Ireland could face medicine shortages after Brexit grace period ends next year, report claims
27/09/2021
Leading pharmaceutical research firm finds some drug firms will withdraw up to 90 per cent of their products from Northern Ireland as protocol hits exports.